Skip to main content
XERS logo

XERS · Xeris Biopharma Holdings, Inc. · Analyst Estimates

Track XERS — free
$10.13 +1.05 (+11.56%)
Market Cap
$1.66B
Shares
182.32M
Volume · Oct 5 4.28M Avg daily vol (3M) 2.17M

Analyst Estimates

Compare analyst forecasts for Xeris Biopharma Holdings, Inc. across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Compiled consensus

These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.

Captured 2026-09-18 21:02 UTC · Publication dates shown per estimate · 16 metric / period groups

FY ending 2026-12-31

Analyst estimates for FY ending 2026-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-0.06
-0.00333
0.08
—
-0.00333
0.14
-0.00333
0.1425
— — — —
EPS
analysts
Publication date not stated
— — —
3
— — — —
3
0
0
0
Revenue
USD
Publication date not stated
385700000
387487830
390900000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
6
— — — — — — — —

FY ending 2027-12-31

Analyst estimates for FY ending 2027-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
0.25
0.39
0.63
—
0.39
0.3925
0.39
0.395
— — — —
EPS
analysts
Publication date not stated
— — —
3
— — — —
0
0
3
0
Revenue
USD
Publication date not stated
458500000
480700000
510100000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
6
— — — — — — — —

Q ending 2026-09-30

Analyst estimates for Q ending 2026-09-30
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-0.15
-0.02
0.05
—
-0.02
0.04
-0.02
0.0425
— — — —
EPS
analysts
Publication date not stated
— — —
3
— — — —
1
0
1
0
Revenue
USD
Publication date not stated
100000000
101558330
102250000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
6
— — — — — — — —

Q ending 2026-12-31

Analyst estimates for Q ending 2026-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
0.05
0.055
0.06
—
0.17
0.0775
0.17
0.08
— — — —
EPS
analysts
Publication date not stated
— — —
2
— — — —
2
0
1
0
Revenue
USD
Publication date not stated
109250000
110725000
113500000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
6
— — — — — — — —
Key facts CIK 1867096 CUSIP 98422E103 13F (30d) 4 filings 4 filers Visit website Investor relations